Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$3.3 billion.

  • Sanofi's Consolidated Net Income fell 165531.31% to -$3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 437241.82%. This contributed to the annual value of $3.2 billion for FY2025, which is 478879.8% up from last year.
  • Sanofi's Consolidated Net Income amounted to -$3.3 billion in Q4 2025, which was down 165531.31% from $3.3 billion recorded in Q3 2025.
  • Sanofi's Consolidated Net Income's 5-year high stood at $12.2 billion during Q4 2022, with a 5-year trough of -$3.3 billion in Q4 2025.
  • In the last 5 years, Sanofi's Consolidated Net Income had a median value of $2.4 billion in 2021 and averaged $2.2 billion.
  • Examining YoY changes over the last 5 years, Sanofi's Consolidated Net Income showed a top increase of 751383.86% in 2025 and a maximum decrease of 165531.31% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Consolidated Net Income stood at $289.9 million in 2021, then soared by 4125.54% to $12.2 billion in 2022, then crashed by 103.86% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then plummeted by 1655.31% to -$3.3 billion in 2025.
  • Its Consolidated Net Income stands at -$3.3 billion for Q4 2025, versus $3.3 billion for Q3 2025 and $3.1 billion for Q2 2025.